Subgroup analysis based on location of the primary tumor revealed a significant benefit in terms of OS in patients with UBC [HR 0.67 (0.51–0.88)], while in patients with UTUC it did not reach statistical significance [HR 0.85 (0.57–1.27)] ( 65 ).
← all excerpts
Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literature.
1
—
—